Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L. Ilag

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Diabetes, Obesity & Metabolism|October 1, 2010
Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetesS M Jain, X Mao, M Escalante-Pulido, et al.
Journal of Molecular Biology|February 5, 1993
Role of DNA-protein interactions in bacteriophage phi X174 DNA injectionL L Ilag, J K Tuech, L A Beisner, et al.
Biochemistry|May 31, 1991
Differences in secondary structure between packaged and unpackaged single-stranded DNA of bacteriophage phi X174 determined by Raman spectroscopy: a model for phi X174 DNA packagingJ M Benevides, P L Stow, L L Ilag, et al.
Diabetes Care|August 28, 2001
Does microalbuminuria predict diabetic nephropathy?B P Tabaei, A S Al-Kassab, L L Ilag, et al.
Diabetes, Obesity & Metabolism|January 11, 2016
Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargineI Hadjiyianni, D Dahl, L B Lacaya, et al.
Journal of Molecular Biology|December 2, 1994
Calcium ion-induced structural changes in bacteriophage phi X174L L Ilag, R McKenna, M P Yadav, et al.
Nature|September 26, 1997
Structure of a viral procapsid with molecular scaffoldingT Dokland, R McKenna, L L Ilag, et al.
Diabetes|June 24, 2000
Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 geneL L Ilag, B P Tabaei, W H Herman, et al.
Diabetes, Obesity & Metabolism|May 2, 2015
Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study)J Rosenstock, P Hollander, A Bhargava, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigenM Rheinnecker, C Hardt, L L Ilag, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Diabetes, Obesity & Metabolism|October 1, 2010
Prandial-basal insulin regimens plus oral antihyperglycaemic agents to improve mealtime glycaemia: initiate and progressively advance insulin therapy in type 2 diabetesS M Jain, X Mao, M Escalante-Pulido, et al.
Journal of Molecular Biology|February 5, 1993
Role of DNA-protein interactions in bacteriophage phi X174 DNA injectionL L Ilag, J K Tuech, L A Beisner, et al.
Biochemistry|May 31, 1991
Differences in secondary structure between packaged and unpackaged single-stranded DNA of bacteriophage phi X174 determined by Raman spectroscopy: a model for phi X174 DNA packagingJ M Benevides, P L Stow, L L Ilag, et al.
Diabetes Care|August 28, 2001
Does microalbuminuria predict diabetic nephropathy?B P Tabaei, A S Al-Kassab, L L Ilag, et al.
Diabetes, Obesity & Metabolism|January 11, 2016
Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargineI Hadjiyianni, D Dahl, L B Lacaya, et al.
Journal of Molecular Biology|December 2, 1994
Calcium ion-induced structural changes in bacteriophage phi X174L L Ilag, R McKenna, M P Yadav, et al.
Nature|September 26, 1997
Structure of a viral procapsid with molecular scaffoldingT Dokland, R McKenna, L L Ilag, et al.
Diabetes|June 24, 2000
Reduced pancreatic polypeptide response to hypoglycemia and amylin response to arginine in subjects with a mutation in the HNF-4alpha/MODY1 geneL L Ilag, B P Tabaei, W H Herman, et al.
Diabetes, Obesity & Metabolism|May 2, 2015
Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study)J Rosenstock, P Hollander, A Bhargava, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1996
Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigenM Rheinnecker, C Hardt, L L Ilag, et al.
Pageof 4